Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43.4M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
1.84M
-
Shares change
-
+1.84M
-
Total reported value, excl. options
-
$25.9M
-
Value change
-
+$25.9M
-
Number of buys
-
28
-
Price
-
$14.05
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q1 2018
28 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q1 2018.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.84M shares
of 43.4M outstanding shares and own 4.25% of the company stock.
Largest 10 shareholders include First Eagle Investment Management, LLC (500K shares), VANGUARD GROUP INC (452K shares), BlackRock Inc. (395K shares), STATE STREET CORP (118K shares), NORTHERN TRUST CORP (75.2K shares), GEODE CAPITAL MANAGEMENT, LLC (71.2K shares), CITIGROUP INC (56K shares), P.A.W. CAPITAL CORP (30K shares), MORGAN STANLEY (23.3K shares), and Bank of New York Mellon Corp (22.3K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.